The Effect of Irrisept for Irrigation of Skin and Soft Tissue Infections (Irrisept USF Study)

NATerminatedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Skin and Soft Tissue InfectionsAbscess
Interventions
DEVICE

Standard of Care (SoC)

The preferred irrigation solution and method was chosen by the site's emergency department physician(s) and could vary between subjects. The type of SoC was recorded in the source document and the same solution and irrigation method were used during the initial treatment and 48-hour follow-up visits.

DEVICE

Irrisept Delivery System

"Irrisept is a manual, self-contained irrigation device capable of producing 7-8 psi of pressure for effective wound cleansing and irrigation. Irrisept contents include the Chlorhexidine Gluconate (CHG) solution, a 450 mL bottle, and Irriprobe applicator or an abscess irrigation tip. The bottle design allows users to control the pressure of the solution through manual bottle compression.~Irrisept was recorded in the source document and used during the initial treatment and 48-hour follow-up visits."

Trial Locations (1)

33606

Tampa General Hospital - University of South Florida, Tampa

Sponsors
All Listed Sponsors
lead

Irrimax Corporation

INDUSTRY

NCT01076049 - The Effect of Irrisept for Irrigation of Skin and Soft Tissue Infections (Irrisept USF Study) | Biotech Hunter | Biotech Hunter